{"transactions":[{"id":1947913,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":115439,"kind":"person","name":"Deniger Drew","position":1,"cik":"0001921961","reported_name":"Deniger Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-18T00:30:12.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from March 15, 2023, with the first vesting occuring on June 15, 2023, subject to the Reporting Person's continued service through each such date."}],"balance_after":125000,"derivative":{"exercise_price":0.5,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-23-008999","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924323008999/doc4.xml","form_type":"4"}},{"id":2156289,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":115439,"kind":"person","name":"Deniger Drew","position":1,"cik":"0001921961","reported_name":"Deniger Drew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research and Development"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-09-19T20:30:41.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":305000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in a series of sixteen equal quarterly installments measured from September 15, 2022, with the first vesting occurring on December 15, 2022, subject to the Reporting Person's continuous service through each such date."}],"balance_after":305000,"derivative":{"exercise_price":2.11,"expiration_date":"2032-09-14","underlying":"Common Stock","underlying_shares":305000},"source":{"system":"sec-edgar","filing":"0000899243-22-031464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000089924322031464/doc4.xml","form_type":"4"}}]}